These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24050080)

  • 1. Prevalence of toenail onychomycosis among diabetics at a primary care facility in Malaysia.
    Leelavathi M; Azimah MN; Kharuddin NF; Tzar MN
    Southeast Asian J Trop Med Public Health; 2013 May; 44(3):479-83. PubMed ID: 24050080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of tinea pedis and toenail onychomycosis prevalence in patients with psoriasis].
    Altunay ZT; Ilkit M; Denli Y
    Mikrobiyol Bul; 2009 Jul; 43(3):439-47. PubMed ID: 19795619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns.
    Eba M; Njunda AL; Mouliom RN; Kwenti ET; Fuh AN; Nchanji GT; Atashili J
    BMC Res Notes; 2016 Nov; 9(1):494. PubMed ID: 27876085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Risk Factors, and Type of Organism in Fungal Foot Infection and Toenail Onychomycosis in Thai Diabetic Patients.
    Assadamongkol R; Lertwattanarak R; Wannachalee T; Bunyaratavej S; Leeyaphan C; Matthapan L
    J Med Assoc Thai; 2016 Jun; 99(6):659-64. PubMed ID: 29900728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Fungal Species of Onychomycosis between Diabetic and Non-Diabetic Patients.
    Sultana S; Jaigirdar QH; Islam MA; Azad AK
    Mymensingh Med J; 2018 Oct; 27(4):752-756. PubMed ID: 30487490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with presence and severity of toenail onychomycosis in patients with diabetes: a cross-sectional study.
    Takehara K; Oe M; Tsunemi Y; Nagase T; Ohashi Y; Iizaka S; Ueki K; Tsukamoto K; Kadowaki T; Sanada H
    Int J Nurs Stud; 2011 Sep; 48(9):1101-8. PubMed ID: 21367414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice.
    Svejgaard EL; Nilsson J
    Mycoses; 2004 Apr; 47(3-4):131-5. PubMed ID: 15078429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and mycologic characteristics of onychomycosis in diabetic patients.
    Al-Mutairi N; Eassa BI; Al-Rqobah DA
    Acta Dermatovenerol Croat; 2010; 18(2):84-91. PubMed ID: 20624357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toenail onychomycosis: an important global disease burden.
    Thomas J; Jacobson GA; Narkowicz CK; Peterson GM; Burnet H; Sharpe C
    J Clin Pharm Ther; 2010 Oct; 35(5):497-519. PubMed ID: 20831675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nail under fungal siege in patients with type II diabetes mellitus.
    Piérard GE; Piérard-Franchimont C
    Mycoses; 2005 Sep; 48(5):339-42. PubMed ID: 16115105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of onychomycosis in Isfahan, Iran.
    Chadeganipour M; Nilipour S; Ahmadi G
    Mycoses; 2010 Mar; 53(2):153-7. PubMed ID: 19298358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of onychomycosis among psoriatic patients in Israel.
    Leibovici V; Hershko K; Ingber A; Westerman M; Leviatan-Strauss N; Hochberg M
    Acta Derm Venereol; 2008; 88(1):31-3. PubMed ID: 18176747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Population-based study of Toenail onychomycosis in Israeli children.
    Leibovici V; Evron R; Dunchin M; Westerman M; Ingber A
    Pediatr Dermatol; 2009; 26(1):95-7. PubMed ID: 19250420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of toe nail onychomycosis in diabetic patients.
    Saunte DM; Holgersen JB; Haedersdal M; Strauss G; Bitsch M; Svendsen OL; Arendrup MC; Svejgaard EL
    Acta Derm Venereol; 2006; 86(5):425-8. PubMed ID: 16955188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology and management of onychomycosis in private dermatological practice in France].
    Guibal F; Baran R; Duhard E; Feuilhade de Chauvin M
    Ann Dermatol Venereol; 2008; 135(8-9):561-6. PubMed ID: 18789289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of toenail dystrophy predicts histologic diagnosis of onychomycosis.
    Walling HW; Sniezek PJ
    J Am Acad Dermatol; 2007 Jun; 56(6):945-8. PubMed ID: 17368630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients.
    Kuvandik G; Cetin M; Genctoy G; Horoz M; Duru M; Akcali C; Satar S; Kiykim AA; Kaya H
    BMC Infect Dis; 2007 Aug; 7():102. PubMed ID: 17760994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in patients with toenail onychomycosis.
    Milobratović D; Janković S; Vukičević J; Marinković J; Janković J; Railić Z
    Mycoses; 2013 Sep; 56(5):543-51. PubMed ID: 23496237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis. A Mexican survey.
    Arenas R; Bonifaz A; Padilla MC; Arce M; Atoche C; Barba J; Campos P; Fernández R; Mayorga J; Nazar D; Ocampo J
    Eur J Dermatol; 2010; 20(5):611-4. PubMed ID: 20605771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onychomycosis: rationalization of topical treatment.
    Shemer A; Trau H; Davidovici B; Amichai B; Grunwald MH
    Isr Med Assoc J; 2008 Jun; 10(6):415-6. PubMed ID: 18669135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.